Long-Term Outcome of Rabbit Anti-Thymocyte Globulin and Cyclosporine Therapy for Pediatric Severe Aplastic Anemia
In May 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Blood Science. The title of the study is "An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for pediatric severe aplastic anemia". This study holds significant implications for the clinical management of pediatric severe aplastic anemia.